Previous Close | 244.50 |
Open | 243.01 |
Bid | 241.01 x 800 |
Ask | 252.73 x 1000 |
Day's Range | 242.61 - 248.03 |
52 Week Range | 200.32 - 290.20 |
Volume | |
Avg. Volume | 666,788 |
Market Cap | 21.905B |
Beta (5Y Monthly) | 1.05 |
PE Ratio (TTM) | 13.17 |
EPS (TTM) | 18.78 |
Earnings Date | Feb 16, 2023 |
Forward Dividend & Yield | 2.88 (1.18%) |
Ex-Dividend Date | Feb 22, 2023 |
1y Target Est | 280.62 |
Subscribe to Yahoo Finance Plus to view Fair Value for LH
Continued increase in Cologuard volume is likely to have benefited Exact Sciences (EXAS) Q4 performance.
Severe currency headwinds are expected to have affected Medtronic's (MDT) profitability in fiscal Q3.
In terms of portfolio enhancement, LabCorp (LH) enters into a collaboration with Becton, Dickinson and Company to advance in life-changing treatments for cancer and other diseases.